Characterization of a Stable, Metronidazole-Resistant Clostridium difficile Clinical Isolate

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Lynch, Tarah ^a   Chong, Patrick ^a   Zhang, Jason ^a   Hizon, Romeo ^a   Du, Tim ^a   Graham, Morag R ^a   Beniac, Daniel R ^a   Booth, Timothy F ^a   Kibsey, Pamela ^b   Miller, Mark ^c   Gravel, Denise ^d   Mulvey, Michael R ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b VICTORIA GENERAL HOSPITAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; METRONIDAZOLE; MOXIFLOXACIN; RIFAMPICIN; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATION; CELL STRUCTURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; ELECTRON TRANSPORT; ENERGY YIELD; GENE SEQUENCE; GENETIC VARIABILITY; GENOMICS; GENOTYPE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPIC VARIATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; GENOMICS; HUMANS; METRONIDAZOLE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

CLOSTRIDIUM DIFFICILE; POSIBACTERIA;

EID: 84872549775     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053757     Document Type: Article

References (67)

1. Kyne L, Hamel MB, Polavaram R, Kelly CP (2002) Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clinical Infectious Diseases 34 (3) ():: 346-353 20 March 2012.
2. Johnson S, Samore MH, Farrow KA, Killgore GE, Tenover FC, et al. (1999) Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 341 (22) (): 1645-1651 20 March 2012.
3. Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, et al. (2004) Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: A changing pattern of disease severity. CMAJ 171 (5) (): 466-472 10.1503/cmaj.1041104.
4. Gravel D, Miller M, Simor A, Taylor G, Gardam M, et al. (2009) Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: A Canadian nosocomial infection surveillance program study. Clinical Infectious Diseases 48 (5) (): 568-576 8 March 2012.
5. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, et al. (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353 (23) (): 2433-2441 10.1056/NEJMoa051590.
6. Anonymous (2005) Severe Clostridium difficile-associated disease in populations previously at low risk- four states, 2005. Morb Mortal Weekly Rep 54 (47) (): 1201-1205 20 March 2012.
7. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, et al. (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infection Control and Hospital Epidemiology 31 (5) (): 431-455 13 March 2012.
8. Bolton RP, Culshaw MA, (1986) Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut 27 (10) (): 1169-1172.
9. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB, (2007) A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 45 (3) (): 302-307 10.1086/519265.
10. Sakka V, Tsiodras S, Galani L, Antoniadou A, Souli M, et al. (2008) Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clinical Microbiology and Infection 14 (1) (): 14-21 20 March 2012.
11. Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, et al. (2011) Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 364 (5) (): 422-431 7 August 2012.
12. Musher DM, Aslam S, Logan N, Nallacheru S, Bhaila I, et al. (2005) Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 40 (11) (): 1586-1590 10.1086/430311.
13. Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, et al. (2000) Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 38 (6) (): 2386-2388.
14. Spigaglia P, Barbanti F, Mastrantonio P, Ackermann G, Balmelli C, et al. (2011) Multidrug resistance in European Clostridium difficile clinical isolates. J Antimicrob Chemother 66 (10) (): 2227-2234 13 March 2012.
15. Tenover FC, Tickler IA, Persing DH, (2012) Antimicrobial resistant strains of Clostridium difficile from North America. Antimicrob Agents Chemother 10.1128/AAC.00220-12.
16. Oka K, Osaki T, Hanawa T, Kurata S, Okazaki M, et al. (2012) Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases. J Clin Microbiol 50 (3) (): 915-921 10.1128/JCM.05588.
17. Lin Y-, Huang Y-, Tsai P-, Lee T-, Lee N-, et al. (2011) Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in Taiwan. Antimicrob Agents Chemother 55 (4) (): 1701-1705 8 March 2012.
18. Baines SD, O'Connor R, Freeman J, Fawley WN, Harmanus C, et al. (2008) Emergence of reduced susceptibility to metronidazole in Clostridium difficile. J Antimicrob Chemother 62 (5) (): 1046-1052 10.1093/jac/dkn313. 2 March 2012.
19. Huang H, Weintraub A, Fang H, Nord CE, (2009) Antimicrobial resistance in Clostridium difficile. Int J Antimicrob Agents 34 (6) (): 516-522 10.1016/j.ijantimicag.2009.09.012.
20. Martin H, Willey B, Low DE, Staempfli HR, McGeer A, et al. (2008) Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006. J Clin Microbiol 46 (9) (): 2999-3004 10.1128/JCM.02437.
21. Peláez T, Sanchez R, Blazquez R, Catalan P, Munoz P, E Bouza (4-7 October 1994) Metronidazole resistance in Clostridium difficile: A new emerging problem? Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Orlando, FL.(Abstract E-34:50).
22. Peláez T, Alcalá L, Alonso R, Rodríguez-Créixems M, García-Lechuz JM, et al. (2002) Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother 46 (6) (): 1647-1650 10.1128/AAC.46.6.1647-1650.2002. 2 March 2012.
23. Peláez T, Cercenado E, Alcalá L, Marín M, Martín-López A, et al. (2008) Metronidazole resistance in Clostridium difficile is heterogeneous. J Clin Microbiol 46 (9) (): 3028-3032 10.1128/JCM.00524-08. 2 March 2012.
24. Indra A, Schmid D, Huhulescu S, Hell M, Gattringer R, et al. (2008) Characterization of clinical Clostridium difficile isolates by PCR ribotyping and detection of toxin genes in Austria, 2006-2007. J Med Microbiol 57 (Pt 6) (): 702-708 10.1099/jmm.0.47476-0.
25. Albert TJ, Dailidiene D, Dailide G, Norton JE, Kalia A, et al. (2005) Mutation discovery in bacterial genomes: Metronidazole resistance in Helicobacter pylori. Nature Methods 2 (12) (): 951-953 27 March 2012.
26. Gal M, Brazier JS, (2004) Metronidazole resistance in Bacteroides spp. carrying nim genes and the selection of slow-growing metronidazole-resistant mutants. J Antimicrob Chemother 54 (1) (): 109-116 27 March 2012.
27. Kaakoush NO, Asencio C, Mégraud F, Mendz GL, (2009) A redox basis for metronidazole resistance in Helicobacter pylori. Antimicrob Agents Chemother 53 (5) (): 1884-1891 10.1128/AAC.01449-08. 2 March 2012.
28. Steffens LS, Nicholson S, Paul LV, Nord CE, Patrick S, et al. (2010) Bacteroides fragilis RecA protein overexpression causes resistance to metronidazole. Res Microbiol 161 (5) (): 346-354 10.1016/j.resmic.2010.04.003.
29. Haggoud A, Reysset G, Azeddoug H, Sebald M (1994) Nucleotide sequence analysis of two 5-nitroimidazole resistance determinants from Bacteroides strains and of a new insertion sequence upstream of the two genes. Antimicrob Agents Chemother 38 (5) (()): 1047-1051. 27 March 2012.
30. Reysset G, Haggoud A, Sebald M, (1993) Genetics of resistance of bacteroides species to 5-nitroimidazole. Clinical Infectious Diseases 16 (SUPPL. 4) (): S401-S403 27 March 2012.
31. Reysset G, Trinh S, Carlier J-, Sebald M, (1996) Genetic basis of 5-nitroimidazole resistance in Bacteroides spp. Med Mal Infect 26 (SPEC. ISS. MAR.) (): 213-219 27 March 2012.
32. Diniz CG, Farias LM, Carvalho MAR, Rocha ER, Smith CJ, (2004) Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant. J Antimicrob Chemother 54 (1) (): 100-108 27 March 2012.
33. Jeong J-, Mukhopadhyay AK, Dailidiene D, Wang Y, Velapatino B, et al. (2000) Sequential inactivation of rdxA (hp0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori. J Bacteriol 182 (18) (): 5082-5090 28 March 2012.
34. Sisson G, Jeong J-, Goodwin A, Bryden L, Rossler N, et al. (2000) Metronidazole activation is mutagenic and causes DNA fragmentation in Helicobacter pylori and in Escherichia coli containing a cloned H. pylori rdxA+ (nitroreductase) gene. J Bacteriol 182 (18) (): 5091-5096 28 March 2012.
35. Goodwin A, Kersulyte D, Sisson G, Veldhuyzen Van Zanten SJO, Berg DE, et al. (1998) Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Mol Microbiol 28 (2) (()): 383-393. 15 July 2012.
36. Chang K, Ho S, Yang J, Wang J (1997) Isolation of a genetic locus associated with metronidazole resistance in Helicobacter pylori. Biochem Biophys Res Commun 236 (3) (()): 785-788. 7 August 2012.
37. Tsugawa H, Suzuki H, Muraoka H, Ikeda F, Hirata K, et al. (2011) Enhanced bacterial efflux system is the first step to the development of metronidazole resistance in Helicobacter pylori. Biochem Biophys Res Commun 404 (2) (): 656-660 27 March 2012.
38. Choi SS, Chivers PT, Berg DE, (2011) Point mutations in Helicobacter pylori's fur regulatory gene that alters resistance to metronidazole, a prodrug activated by chemical reduction. PLoS One 6 (3) (): e18236 10.1371/journal.pone.0018236.
39. Yuan L, Vogel A (2006) Evidence review: Communicable disease surveillance. Population Health and Wellness: BC Ministry of Health.
40. Miller M, Gravel D, Mulvey M, Taylor G, Boyd D, et al. (2010) Health care-associated Clostridium difficile infection in Canada: Patient age and infecting strain type are highly predictive of severe outcome and mortality. Clinical Infectious Diseases 50 (2) (): 194-201 13 March 2012.
41. Spigaglia P, Mastrantonio P, (2004) Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J Med Microbiol 53 (Pt 11) (): 1129-1136.
42. Lemee L, Dhalluin A, Testelin S, Mattrat MA, Maillard K, et al. (2004) Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (toxin A), and tcdB (toxin B) genes for toxigenic culture of Clostridium difficile. J Clin Microbiol 42 (12) (): 5710-5714 10.1128/JCM.42.12.5710-5714.2004.
43. Alfa MJ, Kabani A, Lyerly D, Moncrief S, Neville LM, et al. (2000) Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 38 (7) (): 2706-2714.
44. Murray R, Boyd D, Levett PN, Mulvey MR, Alfa MJ, (2009) Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of toxin B or toxin A. BMC Infectious Diseases 97 August 2012.
45. Abramoff MD, Magelhaes PJ, Ram SJ, (2004) Image processing with ImageJ. Biophotonics International 11: 36.
46. Clinical and Laboratory Standards Institute (CLSI) (2007) Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard- seventh edition, M11-A7.
47. Forgetta V, Oughton MT, Marquis P, Brukner I, Blanchette R, et al. (2011) Fourteen-genome comparison identifies DNA markers for severe-disease- associated strains of Clostridium difficile. J Clin Microbiol 49 (6) (()): 2230-2238. 13 March 2012.
48. Stabler RA, He M, Dawson L, Martin M, Valiente E, et al. (2009) Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol 10 (9) () 15 August 2012.
49. Bonfield JK, Smith K, Staden R, (1995) A new DNA sequence assembly program. Nucleic Acids Res 23 (24) (): 4992-4999.
50. Meyer F, Goesmann A, McHardy AC, Bartels D, Bekel T, et al. (2003) GenDB-an open source genome annotation system for prokaryote genomes. Nucleic Acids Res 31 (8) (): 2187-2195.
51. Petkau A, Stuart-Edwards M, Stothard P, Van Domselaar G, (2010) Interactive microbial genome visualization with GView. Bioinformatics 26 (24) (): 3125-3126 10.1093/bioinformatics/btq588.
52. Li H, Durbin R, (2009) Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics 25 (14) (): 1754-1760 29 March 2012.
53. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. (2009) The sequence Alignment/Map format and SAMtools. Bioinformatics 25 (16) (): 2078-2079 29 March 2012.
54. Danecek P, Auton A, Abecasis G, Albers CA, Banks E, et al. (2011) The variant call format and VCFtools. Bioinformatics 27 (15) (): 2156-2158 15 August 2012.
55. Spigaglia P, Mastrantonio P, (2002) Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 40 (9) (): 3470-3475 22 March 2012.
56. Brouwer MS, Warburton PJ, Roberts AP, Mullany P, Allan E, (2011) Genetic organisation, mobility and predicted functions of genes on integrated, mobile genetic elements in sequenced strains of Clostridium difficile. PLoS One 6 (8) (): e23014 10.1371/journal.pone.0023014.
57. Bourgault A-, Lamothe F, Loo VG, Poirier L, (2006) In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in southern Québec, Canada. Antimicrob Agents Chemother 50 (10) (): 3473-3475 29 March 2012.
58. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, et al. (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile- associated diarrhea with high morbidity and mortality. N Engl J Med 353 (23) (): 2442-2449 29 March 2012.
59. Edwards DI, (1993) Nitroimidazole drugs- action and resistance mechanisms I. mechanisms of action. J Antimicrob Chemother 31 (1) (): 9-20 14 August 2012.
60. Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, et al. (2006) Small colony variants: A pathogenic form of bacteria that facilitates persistent and recurrent infections. Nature Reviews Microbiology 4 (4) (): 295-305 13 July 2012.
61. Gröbner S, Beck J, Schaller M, Autenrieth IB, Schulte B, (2012) Characterization of an Enterococcus faecium small-colony variant isolated from blood culture. International Journal of Medical Microbiology 302 (1) (): 40-44 14 August 2012.
62. Wellinghausen N, Chatterjee I, Berger A, Niederfuehr A, Proctor RA, et al. (2009) Characterization of clinical Enterococcus faecalis small-colony variants. J Clin Microbiol 47 (9) (): 2802-2811 14 August 2012.
63. Kahl BC, Belling G, Reichelt R, Herrmann M, Proctor RA, et al. (2003) Thymidine-dependent small-colony variants of Staphylococcus aureus exhibit gross morphological and ultrastructural changes consistent with impaired cell separation. J Clin Microbiol 41 (1) (()): 410-413. 13 July 2012.
64. Burns DA, Minton NP, (2011) Sporulation studies in Clostridium difficile. J Microbiol Methods 87 (2) (): 133-138 14 August 2012.
65. Underwood S, Guan S, Vijayasubhash V, Baines SD, Graham L, et al. (2009) Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production. J Bacteriol 191 (23) (): 7296-7305 14 August 2012.
66. Tsugawa H, Suzuki H, Satoh K, Hirata K, Matsuzaki J, et al. (2011) Two amino acids mutation of ferric uptake regulator determines Helicobacter pylori resistance to metronidazole. Antioxidants and Redox Signaling 14 (1) (): 15-23 14 August 2012.
67. Helmann JD, Wu MFW, Gaballa A, Kobel PA, Morshedi MM, et al. (2003) The global transcriptional response of Bacillus subtilis to peroxide stress is coordinated by three transcription factors. J Bacteriol 185 (1) (): 243-253 14 August 2012.